Florian Rader

Cardiology

127 S San Vicente Blvd
Los Angeles,, CA 90048

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 130 publications

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Journal: Circulation

Published: August 29, 2026

Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Journal: The New England journal of medicine

Published: August 28, 2026

Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM.

Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM.

Journal: Circulation

Published: August 28, 2026

Refining sudden cardiac death risk in hypertrophic cardiomyopathy: The interplay between atrial and ventricular arrhythmias.

Refining sudden cardiac death risk in hypertrophic cardiomyopathy: The interplay between atrial and ventricular arrhythmias.

Journal: Progress in cardiovascular diseases

Published: April 28, 2026

AMCP Market Insights: Getting to the heart of hard-to-control hypertension in managed care.

AMCP Market Insights: Getting to the heart of hard-to-control hypertension in managed care.

Journal: Journal of managed care & specialty pharmacy

Published: April 27, 2026

Injectables for the Treatment of Hypertension: A Look Into the Future?

Injectables for the Treatment of Hypertension: A Look Into the Future?

Journal: Journal of the American College of Cardiology

Published: March 18, 2026

Blood Pressure-Adaptive Atrial Pacing Narrows Pulse Pressure in Hypertensive HFpEF.

Blood Pressure-Adaptive Atrial Pacing Narrows Pulse Pressure in Hypertensive HFpEF.

Journal: The American journal of cardiology

Published: March 02, 2026

Artificial Intelligence for the Detection of Hypertrophic Cardiomyopathy From Standard Electrocardiogram.

Artificial Intelligence for the Detection of Hypertrophic Cardiomyopathy From Standard Electrocardiogram.

Journal: JACC. Advances

Published: October 16, 2025

Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy.

Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy.

Journal: Circulation

Published: September 22, 2025

Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design.

Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design.

Journal: JACC. Advances

Published: September 19, 2025

The Aldosterone Plot Thickens.

The Aldosterone Plot Thickens.

Journal: American journal of hypertension

Published: September 17, 2025

High rate of seroeligibility among MYBPC3-associated hypertrophic cardiomyopathy patients for TN-201, an adeno-associated virus serotype 9 MYBPC3 gene therapy.

High rate of seroeligibility among MYBPC3-associated hypertrophic cardiomyopathy patients for TN-201, an adeno-associated virus serotype 9 MYBPC3 gene therapy.

Journal: Frontiers in medicine

Published: June 30, 2025

Showing 1-12 of 130

Last Updated: 09/26/2026